PortfoliosLab logoPortfoliosLab logo
GENE.L vs. MWRD.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

GENE.L vs. MWRD.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in UBS ETF (IE) Global Gender Equality UCITS ETF (USD) A-acc (GENE.L) and Amundi Index MSCI World (MWRD.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


GENE.L

1D
0.53%
1M
0.84%
YTD
3.70%
6M
6.46%
1Y
16.95%
3Y*
12.36%
5Y*
8.55%
10Y*

MWRD.L

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

GENE.L vs. MWRD.L - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
GENE.L
UBS ETF (IE) Global Gender Equality UCITS ETF (USD) A-acc
3.70%14.86%10.70%11.06%-1.37%17.63%6.95%21.36%-3.99%
MWRD.L
Amundi Index MSCI World
0.00%0.00%-1.27%17.50%-9.18%24.39%11.85%23.29%-6.34%

Correlation

The correlation between GENE.L and MWRD.L is 0.72, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.57

Correlation (All Time)
Calculated using the full available price history since Jul 4, 2018

0.72

The correlation between GENE.L and MWRD.L shifts across timeframes, from 0.26 (3 years) to 0.72 (all time), reflecting how their relationship changes across market environments.

GENE.L vs. MWRD.L - Sectors Allocation Comparison


Sectors
GENE.L
MWRD.L

Financial Services

26.3%
14.7%

Healthcare

12.8%
12.4%

Consumer Cyclical

11.2%
10.5%

Consumer Defensive

10.4%
6.7%

Utilities

8.3%
2.4%

Communication Services

7.8%
7.5%

Real Estate

6.8%
2.4%

Basic Materials

5.8%
3.8%

Technology

5.3%
24.7%

Industrials

5.3%
10.6%

Energy

-

4.4%

Financial Services

GENE.L
26.3%
MWRD.L
14.7%

Healthcare

GENE.L
12.8%
MWRD.L
12.4%

Consumer Cyclical

GENE.L
11.2%
MWRD.L
10.5%

Consumer Defensive

GENE.L
10.4%
MWRD.L
6.7%

Utilities

GENE.L
8.3%
MWRD.L
2.4%

Communication Services

GENE.L
7.8%
MWRD.L
7.5%

Real Estate

GENE.L
6.8%
MWRD.L
2.4%

Basic Materials

GENE.L
5.8%
MWRD.L
3.8%

Technology

GENE.L
5.3%
MWRD.L
24.7%

Industrials

GENE.L
5.3%
MWRD.L
10.6%

Energy

GENE.L

-

MWRD.L
4.4%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GENE.L vs. MWRD.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GENE.L
GENE.L Risk / Return Rank: 4848
Overall Rank
GENE.L Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
GENE.L Sortino Ratio Rank: 4848
Sortino Ratio Rank
GENE.L Omega Ratio Rank: 4545
Omega Ratio Rank
GENE.L Calmar Ratio Rank: 5151
Calmar Ratio Rank
GENE.L Martin Ratio Rank: 5151
Martin Ratio Rank

MWRD.L
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GENE.L vs. MWRD.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for UBS ETF (IE) Global Gender Equality UCITS ETF (USD) A-acc (GENE.L) and Amundi Index MSCI World (MWRD.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GENE.LMWRD.LDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.28

Calmar ratioReturn relative to maximum drawdown

2.49

Martin ratioReturn relative to average drawdown

8.57

GENE.L vs. MWRD.L - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


GENE.LMWRD.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.61

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.66

Sharpe Ratio (All Time)

Calculated using the full available price history

0.67

Drawdowns

GENE.L vs. MWRD.L - Drawdown Comparison


Loading charts...

Drawdown Indicators


GENE.LMWRD.LDifference

Max Drawdown

Largest peak-to-trough decline

-28.65%

Max Drawdown (1Y)

Largest decline over 1 year

-6.79%

Max Drawdown (3Y)

Largest decline over 3 years

-15.04%

Max Drawdown (5Y)

Largest decline over 5 years

-15.04%

Current Drawdown

Current decline from peak

-1.85%

Average Drawdown

Average peak-to-trough decline

-3.70%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.97%

Volatility

GENE.L vs. MWRD.L - Volatility Comparison


Loading charts...

Volatility by Period


GENE.LMWRD.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

2.59%

Volatility (6M)

Calculated over the trailing 6-month period

8.14%

Volatility (1Y)

Calculated over the trailing 1-year period

10.52%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

12.96%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

14.92%

GENE.L vs. MWRD.L - Expense Ratio Comparison

GENE.L has a 0.20% expense ratio, which is higher than MWRD.L's 0.08% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.


Dividends

GENE.L vs. MWRD.L - Dividend Comparison

Neither GENE.L nor MWRD.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


GENE.L and MWRD.L have a correlation of 0.72, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, MWRD.L is cheaper at 0.08% per year. The better choice depends on whether you care most about return, fees, risk, or income.

MWRD.L is cheaper with a 0.08% expense ratio, compared with 0.20% for GENE.L.

Both ETFs track MSCI ACWI NR USD. They also come from different issuers: UBS and Amundi. Their fees differ too: 0.20% for GENE.L and 0.08% for MWRD.L.

Portfolio Optimizer

Find the right allocation for GENE.L and MWRD.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer